Search by Drug Name or NDC

    NDC 71610-0110-60 Doxazosin mesylate 8 mg/1 Details

    Doxazosin mesylate 8 mg/1

    Doxazosin mesylate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is DOXAZOSIN MESYLATE.

    Product Information

    NDC 71610-0110
    Product ID 71610-110_b3e06e81-a608-4bec-9ee6-e7e0085714ca
    Associated GPIs 36202005100340
    GCN Sequence Number 015587
    GCN Sequence Number Description doxazosin mesylate TABLET 8 MG ORAL
    HIC3 J7B
    HIC3 Description ALPHA-ADRENERGIC BLOCKING AGENTS
    GCN 33434
    HICL Sequence Number 006031
    HICL Sequence Number Description DOXAZOSIN MESYLATE
    Brand/Generic Generic
    Proprietary Name Doxazosin mesylate
    Proprietary Name Suffix n/a
    Non-Proprietary Name doxazosin mesylate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 8
    Active Ingredient Units mg/1
    Substance Name DOXAZOSIN MESYLATE
    Labeler Name Aphena Pharma Solutions - Tennessee, LLC
    Pharmaceutical Class Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA019668
    Listing Certified Through 2024-12-31

    Package

    NDC 71610-0110-60 (71610011060)

    NDC Package Code 71610-110-60
    Billing NDC 71610011060
    Package 90 TABLET in 1 BOTTLE (71610-110-60)
    Marketing Start Date 2018-08-20
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 1ef6d4a3-1571-4a65-abca-caaee36be645 Details

    Revised: 8/2018